What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
CIK: 0001601086
Total reported value
$8.2B
$8.2B
253 檔
34.0%
The Q1 2026 SEC filing reveals that Armistice Capital, LLC held a total portfolio value of $8.2B, covering 253 public equity positions.
In Q1 2026, Armistice Capital, LLC adopted a defensive or profit-taking posture, trimming 68 positions and completely liquidating 57 holdings to manage risk exposure.
In terms of portfolio concentration, the top 5 core holdings (including SPY, IWM, AGIO) accounted for 34.0% of total reported equity market value during Q1 2026.
Showing top 200 holdings (of 253 total)
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | SPY | Ss Spdr S&p 500 ETF Trust-us | ETF-Large Cap & Growth | 24.28% | +4.96% | -30.00% | |
| 2 | IWM | Ishares Russell 2000 ETF | ETF-Small Cap | 15.43% | +5.89% | -56.79% | |
| 3 | AGIO | Agios Pharmaceuticals Inc | Stock-Other | 3.56% | -1.19% | -1.99% | |
| 4 | CYTK | Cytokinetics Inc | Stock-Healthcare | 3.12% | -0.27% | +6.89% | |
| 5 | PTCT | Ptc Therapeutics Inc | Stock-Healthcare | 2.99% | -1.26% | -12.04% | |
| 6 | TVTX | Travere Therapeutics Inc | Stock-Other | 2.59% | -1.15% | +30.12% | |
| 7 | MDGL | Madrigal Pharmaceuticals Inc | Stock-Healthcare | 2.46% | -0.57% | -0.42% | |
| 8 | IMVT | Immunovant Inc | Stock-Other | 2.41% | -1.03% | -15.89% | |
| 9 | SUPN | Supernus Pharmaceuticals Inc | Stock-Healthcare | 1.74% | -0.23% | -31.43% | |
| 10 | NBIX | Neurocrine Biosciences Inc | Stock-Healthcare | 1.70% | -0.60% | -11.73% | |
| 11 | FRPT | Freshpet Inc | Stock-Consumer Staples | 1.15% | -0.24% | -15.64% | |
| 12 | INCY | Incyte CORP | Stock-Healthcare | 1.10% | +0.15% | -40.19% | |
| 13 | DYN | Dyne Therapeutics Inc | Stock-Other | 1.02% | -0.18% | -2.30% | |
| 14 | AMZN | Amazon.com Inc | Stock-Consumer Disc | 0.97% | -0.14% | -28.70% | |
| 15 | IRWD | Ironwood Pharmaceuticals Inc | Stock-Other | 0.94% | -0.22% | -6.22% | |
| 16 | S | Sentinelone Inc -class A | Stock-Tech | 0.81% | -0.23% | -36.90% | |
| 17 | HRMY | Harmony Biosciences Holdings | Stock-Other | 0.81% | -0.11% | +224.80% | |
| 18 | TMO | Thermo Fisher Scientific Inc | Stock-Healthcare | 0.80% | -0.05% | +45.60% | |
| 19 | FIVN | Five9 Inc | Stock-Tech | 0.77% | -0.37% | -25.21% | |
| 20 | NKTR | Nektar Therapeutics | Stock-Other | 0.74% | -0.12% | -3.02% | |
| 21 | UNH | Unitedhealth Group Inc | Stock-Healthcare | 0.71% | +0.22% | — | |
| 22 | UBER | Uber Technologies Inc | Stock-Industrials | 0.66% | -0.22% | +83.48% | |
| 23 | PENN | Penn Entertainment Inc | Stock-Consumer Disc | 0.66% | -0.48% | -19.96% | |
| 24 | IMCR | Immunocore Holdings Plc-adr | Stock-Other | 0.64% | -0.09% | +8.20% | |
| 25 | XRAY | Dentsply Sirona Inc | Stock-Healthcare | 0.62% | -0.14% | -58.89% | |
| 26 | RIGL | Rigel Pharmaceuticals Inc | Stock-Other | 0.62% | +0.18% | +53.11% | |
| 27 | IRON | Disc Medicine Inc | Stock-Other | 0.61% | -0.20% | +7.33% | |
| 28 | GOOGL | Alphabet Inc-cl A | Stock-Comm Services | 0.61% | -0.06% | -39.66% | |
| 29 | MLYS | Mineralys Therapeutics Inc | Stock-Other | 0.57% | +0.35% | +73.96% | |
| 30 | HUBS | Hubspot Inc | Stock-Tech | 0.56% | -0.16% | +89.09% | |
| 31 | AXGN | Axogen Inc | Stock-Other | 0.55% | -0.11% | — | |
| 32 | OFIX | Orthofix Medical Inc | Stock-Other | 0.55% | -0.19% | +1.96% | |
| 33 | KURA | Kura Oncology Inc | Stock-Other | 0.54% | -0.05% | -24.31% | |
| 34 | AVNS | Avanos Medical Inc | Stock-Other | 0.50% | -0.50% | EXIT | |
| 35 | REGN | Regeneron Pharmaceuticals | Stock-Healthcare | 0.50% | +0.19% | -56.99% | |
| 36 | ALGN | Align Technology Inc | Stock-Healthcare | 0.48% | -0.11% | +107.56% | |
| 37 | MDB | Mongodb Inc | Stock-Tech | 0.47% | +0.04% | +118.33% | |
| 38 | BABA | Alibaba Group Holding-sp Adr | Stock-Consumer Disc | 0.46% | -0.26% | -36.07% | |
| 39 | MDLN | Medline Inc-cl A | Stock-Other | 0.45% | -0.45% | EXIT | |
| 40 | 4XC1 | Kalvista Pharmaceuticals Inc | Stock-Other | 0.44% | -0.44% | EXIT | |
| 41 | DDOG | Datadog Inc - Class A | Stock-Tech | 0.44% | -0.32% | -14.71% | |
| 42 | HUM | Humana Inc | Stock-Healthcare | 0.44% | -0.09% | +97.05% | |
| 43 | VSTM | Verastem Inc | Stock-Other | 0.43% | -0.10% | +29.86% | |
| 44 | ISRG | Intuitive Surgical Inc | Stock-Healthcare | 0.43% | -0.19% | -14.79% | |
| 45 | GRFS | Grifols Sa-adr | Stock-Other | 0.43% | -0.18% | +7.95% | |
| 46 | SLDB | Solid Biosciences Inc | Stock-Other | 0.41% | +0.11% | +22.51% | |
| 47 | GTLB | Gitlab Inc-cl A | Stock-Tech | 0.40% | +0.10% | +19.76% | |
| 48 | AUTL | Autolus Therapeutics PLC | Stock-Other | 0.39% | -0.10% | -9.71% | |
| 49 | ANGO | Angiodynamics Inc | Stock-Other | 0.38% | -0.03% | +9.94% | |
| 50 | ARVN | Arvinas Inc | Stock-Other | 0.37% | -0.09% | +9.89% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | AGIO | Agios Pharmaceuticals Inc | +1.6% | -1.99% | Trim |
| 2 | CYTK | Cytokinetics Inc | +1.2% | +6.89% | Add |
| 3 | TVTX | Travere Therapeutics Inc | +0.9% | +30.12% | Add |
| 4 | MDGL | Madrigal Pharmaceuticals Inc | +0.6% | -0.42% | Trim |
| 5 | HRMY | Harmony Biosciences Holdings | +0.6% | +224.80% | Add |
| 6 | PTCT | Ptc Therapeutics Inc | +0.5% | -12.04% | Trim |
| 7 | IMVT | Immunovant Inc | +0.4% | -15.89% | Trim |
| 8 | NKTR | Nektar Therapeutics | +0.4% | -3.02% | Trim |
| 9 | MDLN | Medline Inc-cl A | +0.4% | +873.62% | Add |
| 10 | UBER | Uber Technologies Inc | +0.4% | +83.48% | Add |
| 11 | TMO | Thermo Fisher Scientific Inc | +0.4% | +45.60% | Add |
| 12 | ALGN | Align Technology Inc | +0.3% | +107.56% | Add |
| 13 | NBIX | Neurocrine Biosciences Inc | +0.3% | -11.73% | Trim |
| 14 | IRWD | Ironwood Pharmaceuticals Inc | +0.3% | -6.22% | Trim |
| 15 | 4XC1 | Kalvista Pharmaceuticals Inc | +0.3% | +54.50% | Add |
| 16 | MLYS | Mineralys Therapeutics Inc | +0.3% | +73.96% | Add |
| 17 | DYN | Dyne Therapeutics Inc | +0.3% | -2.30% | Trim |
| 18 | HUBS | Hubspot Inc | +0.2% | +89.09% | Add |
| 19 | SLDB | Solid Biosciences Inc | +0.2% | +22.51% | Add |
| 20 | HUM | Humana Inc | +0.2% | +97.05% | Add |
| 21 | MDB | Mongodb Inc | +0.2% | +118.33% | Add |
| 22 | FRPT | Freshpet Inc | +0.2% | -15.64% | Trim |
| 23 | SRRK | Scholar Rock Holding CORP | +0.2% | +68.48% | Add |
| 24 | MGNX | Macrogenics Inc | +0.2% | -4.93% | Trim |
| 25 | TSM | Taiwan Semiconductor-sp Adr | +0.2% | +22.51% | Add |
| 26 | IMCR | Immunocore Holdings Plc-adr | +0.2% | +8.20% | Add |
| 27 | RIGL | Rigel Pharmaceuticals Inc | +0.2% | +53.11% | Add |
| 28 | TOST | Toast Inc-class A | +0.2% | +153.55% | Add |
| 29 | TER | Teradyne Inc | +0.2% | +55.23% | Add |
| 30 | FDMT | 4d Molecular Therapeutics In | +0.2% | +3.31% | Add |
| 31 | IRON | Disc Medicine Inc | +0.1% | +7.33% | Add |
| 32 | INTC | Intel CORP | +0.1% | +82.20% | Add |
| 33 | PENN | Penn Entertainment Inc | +0.1% | -19.96% | Trim |
| 34 | BE | Bloom Energy Corp- A | +0.1% | +987.16% | Add |
| 35 | GRFS | Grifols Sa-adr | +0.1% | +7.95% | Add |
| 36 | SUPN | Supernus Pharmaceuticals Inc | +0.1% | -31.43% | Trim |
| 37 | VSTM | Verastem Inc | +0.1% | +29.86% | Add |
| 38 | ENR | Energizer Holdings Inc | +0.1% | +15.83% | Add |
| 39 | OFIX | Orthofix Medical Inc | +0.1% | +1.96% | Add |
| 40 | AVNS | Avanos Medical Inc | +0.1% | -37.50% | Trim |
| 41 | GLW | Corning Inc | +0.1% | +1127.82% | Add |
| 42 | SNDK | Sandisk CORP | +0.1% | +486.76% | Add |
| 43 | ULTA | Ulta Beauty Inc | +0.1% | +86.44% | Add |
| 44 | PEGA | Pegasystems Inc | +0.1% | +59.42% | Add |
| 45 | WYNN | Wynn Resorts LTD | +0.1% | -1.50% | Trim |
| 46 | FIX | Comfort Systems USA Inc | +0.1% | +652.72% | Add |
| 47 | RBLX | Roblox CORP -class A | +0.1% | +154.12% | Add |
| 48 | VYGR | Voyager Therapeutics Inc | +0.1% | -12.50% | Trim |
| 49 | DDOG | Datadog Inc - Class A | 0% | -14.71% | Trim |
| 50 | EW | Edwards Lifesciences CORP | 0% | -18.97% | Trim |
According to official SEC Form 13F filings, Armistice Capital, LLC reported a total U.S. public equity portfolio value of $8.2B across 253 disclosed positions in Q1 2026.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
Top New Position Initiated
UNH
市值: $40.0M
Top Position Liquidated / Trimmed
ARGX
前期市值: $48.8M
During Q1 2026, Armistice Capital, LLC's top holdings by market value included SPY (24.3%)、IWM (15.4%)、AGIO (3.6%). The largest single position, SPY, represented 24.3% of total portfolio value.
In Q1 2026, Armistice Capital, LLC made 199 total portfolio adjustments, initiating 34 new buys, adding to 40 positions, trimming 68 holdings, and fully liquidating 57 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.